WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Inari Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-08 10:29 am Sale |
2024-09-30 | 13G | Inari Medical, Inc. NARI |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-4,563,325![]() (Position Closed) |
Filing |
2024-02-08 10:14 am Sale |
2023-12-29 | 13G | Inari Medical, Inc. NARI |
WELLINGTON MANAGEMENT CO LLP | 4,563,325 7.920% |
-375,249![]() (-7.60%) |
Filing |
2023-02-06 2:53 pm Purchase |
2022-12-30 | 13G | Inari Medical, Inc. NARI |
WELLINGTON MANAGEMENT CO LLP | 4,938,574 9.200% |
1,787,280![]() (+56.72%) |
Filing |
2022-02-04 09:17 am Purchase |
2021-12-31 | 13G | Inari Medical, Inc. NARI |
WELLINGTON MANAGEMENT CO LLP | 3,151,294 6.280% |
3,151,294![]() (New Position) |
Filing |